Literature DB >> 17223867

Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism.

C Santonocito1, R Capizzi, P Concolino, M M Lavieri, A Paradisi, S Gentileschi, E Torti, S Rutella, S Rocchetti, A Di Carlo, E Di Stasio, F Ameglio, C Zuppi, E Capoluongo.   

Abstract

BACKGROUND: Literature data report an association between some vitamin D receptor (VDR) polymorphisms and different kinds of tumours, including malignant melanoma (MM). Only three VDR polymorphisms (FokI, TaqI and A-1012G) have been investigated in association with the presence of cutaneous MM or the development of metastases.
OBJECTIVES: The present paper analyses for the first time the association between BsmI polymorphism and MM prevalence together with Breslow thickness. In addition, the FokI single nucleotide polymorphism was also determined.
METHODS: One hundred and one patients with MM and 101 healthy donors matched for age and sex were enrolled. Molecular VDR typing was performed by means of restriction fragment length polymorphism analysis.
RESULTS: All cases and controls were in Hardy-Weinberg equilibrium for BsmI, FokI and A-1012G. Significant associations were found between the BsmI bb genotype frequency and MM (P = 0.02) along with Breslow thickness (P = 0.001). This same behaviour was not observed for the FokI or A-1012G polymorphisms. Multivariate logistic regression analysis confirmed these significant results after correction for age, gender, skin type and MM localization.
CONCLUSIONS: Although the biological meaning of the effects exerted by BsmI polymorphism is still under debate, the statistical association found in the present study suggests that further work should be done to verify this variant as a possible risk marker for MM and its aggressiveness, also considering that the real association may be due to other unknown genes linked to the BsmI b allele.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223867     DOI: 10.1111/j.1365-2133.2006.07620.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  24 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

2.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

3.  Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.

Authors:  Nicole Denzer; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

4.  Vitamin D receptor polymorphisms in patients with cutaneous melanoma.

Authors:  Irene Orlow; Pampa Roy; Anne S Reiner; Sarah Yoo; Himali Patel; Susan Paine; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Nancy E Thomas; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Peter A Kanetsky; Klaus Busam; Lynn From; Colin B Begg; Marianne Berwick
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

Review 5.  Vitamin D and skin cancer.

Authors:  Erin M Burns; Craig A Elmets; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2014-12-08       Impact factor: 3.421

6.  Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.

Authors:  Jieyun Yin; Hongliang Liu; Xiaohua Yi; Wenting Wu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Jiali Han; Qingyi Wei
Journal:  Pigment Cell Melanoma Res       Date:  2016-01-29       Impact factor: 4.693

7.  Are tanning beds "safe"? Human studies of melanoma.

Authors:  Marianne Berwick
Journal:  Pigment Cell Melanoma Res       Date:  2008-10       Impact factor: 4.693

8.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

Review 9.  Cytochromes p450 and skin cancer: role of local endocrine pathways.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Igor Semak; Blazej Zbytek; Alexander Pisarchik; Wei Li; Jordan Zjawiony; Robert C Tuckey
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

10.  Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.

Authors:  Shenying Fang; Amaury Vaysse; Myriam Brossard; Yuling Wang; Defeng Deng; Quan Liu; Peter Zhang; Kejing Xu; Ming Li; Runhua Feng; Huey Liu; Yifang Dang; Wei Chen; Victor Prieto; Jeffrey E Gershenwald; Merrick I Ross; Brenna Matejka; Jared Malke; Lauren E Haydu; John D Reveille; Dawen Sui; Roland L Bassett; Nadya Koshkina; Marie Françoise Avril; Mason Lu; Qingyi Wei; Florence Demenais; Christopher I Amos; Jeffrey E Lee
Journal:  J Invest Dermatol       Date:  2016-08-06       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.